首页> 外文期刊>World Journal of Gastroenterology >Synthesis of ribozyme against vascular endothelial growth factor_(165) and its biological activity in vitro
【24h】

Synthesis of ribozyme against vascular endothelial growth factor_(165) and its biological activity in vitro

机译:核酶对血管内皮生长因子_(165)的合成及其体外生物学活性

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the designation, synthesis and biological activity of against vascular endothelial growth factor_(165) (VEGF_(165)) ribozyme. METHODS: The ribozyme against VEGF_(165) was designed with computer. The transcriptional vector was constructed which included the anti-VEGF_(165) ribozyme and 5′, 3′ self-splicing ribozymes. The hammerhead ribozyme and substrate VEGF_(165) mRNA were synthesized through transcription in vitro. The cleavage activity of the ribozyme on target RNA was observed in a cell-free system. RESULTS: The anti-VEGF_(165) ribozyme was released properly from the transcription of pGEMRz212 cleaved by 5′ and 3′ self-splicing ribozymes which retained its catalytic activity, and the cleavage efficiency of ribozyme reached 90.7%. CONCLUSION: The anti-VEGF_(165) ribozyme designed with computer can cleave VEGF_(165) mRNA effectively.
机译:目的:探讨抗血管内皮生长因子_(165)(VEGF_(165))核酶的命名,合成及生物学活性。方法:用计算机设计抗VEGF_(165)的核酶。构建包括抗VEGF_(165)核酶和5',3'自剪接核酶的转录载体。通过体外转录合成锤头状核酶和底物VEGF_(165)mRNA。在无细胞系统中观察到核酶对靶RNA的切割活性。结果:经5'和3'自剪切核酶裂解的pGEMRz212的转录可适当释放抗VEGF_(165)核酶,并保持其催化活性,其裂解效率达到90.7%。结论:计算机设计的抗VEGF_(165)核酶可有效切割VEGF_(165)mRNA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号